Pacira BioSciences Inc (PCRX)
26.25
+0.15
(+0.57%)
USD |
NASDAQ |
Apr 19, 16:00
26.24
-0.01
(-0.04%)
After-Hours: 20:00
Pacira BioSciences Market Cap: 1.221B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 19, 2024 | 1.221B |
| April 18, 2024 | 1.214B |
| April 17, 2024 | 1.245B |
| April 16, 2024 | 1.249B |
| April 15, 2024 | 1.234B |
| April 12, 2024 | 1.248B |
| April 11, 2024 | 1.272B |
| April 10, 2024 | 1.294B |
| April 09, 2024 | 1.326B |
| April 08, 2024 | 1.324B |
| April 05, 2024 | 1.309B |
| April 04, 2024 | 1.321B |
| April 03, 2024 | 1.349B |
| April 02, 2024 | 1.326B |
| April 01, 2024 | 1.355B |
| March 28, 2024 | 1.359B |
| March 27, 2024 | 1.350B |
| March 26, 2024 | 1.326B |
| March 25, 2024 | 1.359B |
| March 22, 2024 | 1.333B |
| March 21, 2024 | 1.362B |
| March 20, 2024 | 1.396B |
| March 19, 2024 | 1.370B |
| March 18, 2024 | 1.362B |
| March 15, 2024 | 1.368B |
| Date | Value |
|---|---|
| March 14, 2024 | 1.361B |
| March 13, 2024 | 1.409B |
| March 12, 2024 | 1.421B |
| March 11, 2024 | 1.442B |
| March 08, 2024 | 1.461B |
| March 07, 2024 | 1.425B |
| March 06, 2024 | 1.400B |
| March 05, 2024 | 1.369B |
| March 04, 2024 | 1.358B |
| March 01, 2024 | 1.342B |
| February 29, 2024 | 1.382B |
| February 28, 2024 | 1.391B |
| February 27, 2024 | 1.388B |
| February 26, 2024 | 1.383B |
| February 23, 2024 | 1.396B |
| February 22, 2024 | 1.393B |
| February 21, 2024 | 1.380B |
| February 20, 2024 | 1.388B |
| February 16, 2024 | 1.352B |
| February 15, 2024 | 1.379B |
| February 14, 2024 | 1.359B |
| February 13, 2024 | 1.358B |
| February 12, 2024 | 1.395B |
| February 09, 2024 | 1.338B |
| February 08, 2024 | 1.288B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.194B
Minimum
Mar 23 2020
3.679B
Maximum
Apr 08 2022
2.174B
Average
2.088B
Median
Apr 19 2023
Market Cap Benchmarks
| Dynavax Technologies Corp | 1.539B |
| Arbutus Biopharma Corp | 491.88M |
| Chimerix Inc | 80.22M |
| Karyopharm Therapeutics Inc | 134.63M |
| FibroGen Inc | 113.59M |
Market Cap Related Metrics
| PE Ratio | 31.63 |
| PS Ratio | 2.129 |
| PEG Ratio | 0.1885 |
| Price to Book Value | 1.403 |
| Price to Free Cash Flow | 10.30 |
| Price | 26.25 |
| Earnings Yield | 3.16% |
| PEGY Ratio | 0.1885 |
| Operating PE Ratio | 16.46 |
| Normalized PE Ratio | 23.21 |